Volumen | 0 |
|
|||||
News | - | ||||||
Tageshoch | Niedrig Hoch |
||||||
Tagestief |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Novan Inc | NOVN | NASDAQ | Common Stock |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
0,0941 | 0,0941 |
Trades | Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0,082 - 1,38 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
- | 0 | US$ 0,0941 | USD |
Finanzwerte NOVN
Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
---|---|---|---|---|---|---|
US$ 2,64M | - | - | - | -18,68 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News Novan
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
25.3.2024 | 13:54 | Edgar (US Regulatory) | Form 8-K - Current report |
05.1.2024 | 15:23 | GlobeNewswire Inc. | Novartis expands production of Pluvicto™ with addition of.. |
11.12.2023 | 01:30 | GlobeNewswire Inc. | Novartis presents new 48-week results from Phase III.. |
08.12.2023 | 15:15 | GlobeNewswire Inc. | Latest Novartis Kisqali® NATALEE analysis reinforces 25%.. |
06.12.2023 | 01:16 | GlobeNewswire Inc. | Novartis receives FDA approval for Fabhalta® (iptacopan),.. |
20.11.2023 | 07:15 | GlobeNewswire Inc. | Novartis showcases significant data updates from Kisqali®,.. |
24.10.2023 | 23:01 | Edgar (US Regulatory) | Form 8-K - Current report |
20.10.2023 | 23:00 | Edgar (US Regulatory) | Form 8-K - Current report |
07.9.2023 | 22:58 | Edgar (US Regulatory) | Form 8-K - Current report |
24.8.2023 | 22:31 | Edgar (US Regulatory) | Form 8-K - Current report |
26.7.2023 | 22:50 | Edgar (US Regulatory) | Form 8-K - Current report |
17.7.2023 | 22:30 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Novan
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NOVN Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 Jahr | 1,32 | 1,38 | 0,082 | 0,3133343 | 1.049.021 | -1,23 | -92,87% |
3 Jahre | 1,10 | 20,74 | 0,082 | 7,02 | 1.007.044 | -1,01 | -91,45% |
5 Jahre | 0,75 | 20,74 | 0,082 | 1,52 | 4.903.096 | -0,6559 | -87,45% |